| 1 |
33427491 | Flavonoids as potential agents in the management of type 2 diabetes through the modulation of α-amylase and α-glucosidase activity: a review. | 2022 |
2 |
| 2 |
35040740 | Application of starch-based nanoparticles and cyclodextrin for prebiotics delivery and controlled glucose release in the human gut: a review. | 2022 Jan 18 |
2 |
| 3 |
35056861 | Anti-α-Glucosidase and Antiglycation Activities of α-Mangostin and New Xanthenone Derivatives: Enzymatic Kinetics and Mechanistic Insights through In Vitro Studies. | 2022 Jan 15 |
1 |
| 4 |
35211990 | Research on antioxidant performance of diglucosyl gallic acid and its application in emulsion cosmetics. | 2022 Apr |
1 |
| 5 |
35397147 | Inhibition of α-amylase and α-glucosidase by Morus australis fruit extract and its components iminosugar, anthocyanin, and glucose. | 2022 Apr |
3 |
| 6 |
35497918 | Correlation of Serum IGF-1R, VEGF, and ET Levels with Bone Mineral Density in Type 2 Diabetic Mellitus Patients Treated with Metformin Plus α-Glucosidase Inhibitors. | 2022 |
1 |
| 7 |
31808390 | Study on the Interaction of 1,5-diaryl Pyrrole Derivatives with α- glucosidase; Synthesis, Molecular Docking, and Kinetic Study. | 2021 |
2 |
| 8 |
32851964 | Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes. | 2021 |
1 |
| 9 |
32926336 | PTP1B and α-glucosidase inhibitors from Selaginella rolandi-principis and their glucose uptake stimulation. | 2021 Jan |
1 |
| 10 |
33092516 | Berberine in the Treatment of Diabetes Mellitus: A Review. | 2021 |
1 |
| 11 |
33288319 | Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies. | 2021 Jan |
1 |
| 12 |
33449919 | The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes. | 2021 Mar |
1 |
| 13 |
33476922 | Comparative study of inhibition mechanisms of structurally different flavonoid compounds on α-glucosidase and synergistic effect with acarbose. | 2021 Jun 15 |
1 |
| 14 |
33658478 | Effects of alpha-glucosidase-inhibiting drugs on acute postprandial glucose and insulin responses: a systematic review and meta-analysis. | 2021 Mar 3 |
1 |
| 15 |
33715179 | An online target and rapid screening method for α-glucosidase inhibitors based on capillary electrophoresis. | 2021 Jun |
1 |
| 16 |
33765180 | Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis. | 2021 Jul |
1 |
| 17 |
33946137 | Hydro-alcoholic extract of Morus nigra reduces fasting blood glucose and HbA1c% in diabetic patients, probably via competitive and allosteric interaction with alpha-glucosidase enzyme; a clinical trial and in silico analysis. | 2021 May 5 |
3 |
| 18 |
34065194 | Synthesis and α-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl]-N-arylacetamides: An In Silico and Biochemical Approach. | 2021 May 20 |
2 |
| 19 |
34124938 | Characterization of an α-Glucosidase Enzyme Conserved in Gardnerella spp. Isolated from the Human Vaginal Microbiome. | 2021 Aug 9 |
1 |
| 20 |
34242650 | The glucose-regulated protein GRP94 interacts avidly in the endoplasmic reticulum with sucrase-isomaltase isoforms that are associated with congenital sucrase-isomaltase deficiency. | 2021 Sep 1 |
1 |
| 21 |
34411978 | Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation. | 2021 Oct |
1 |
| 22 |
34439553 | Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction. | 2021 Aug 18 |
2 |
| 23 |
34527658 | Targeting N-Terminal Human Maltase-Glucoamylase to Unravel Possible Inhibitors Using Molecular Docking, Molecular Dynamics Simulations, and Adaptive Steered Molecular Dynamics Simulations. | 2021 |
1 |
| 24 |
34736132 | Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose. | 2021 Dec |
1 |
| 25 |
34931981 | An Overview of Phytotherapy Used in the Management of Type II Diabetes. | 2021 Jun 17 |
1 |
| 26 |
34944521 | In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes. | 2021 Dec 14 |
1 |
| 27 |
31553294 | Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents. | 2020 |
1 |
| 28 |
31844870 | Emerging strategies for the activity assay and inhibitor screening of alpha-glucosidase. | 2020 Jan 29 |
4 |
| 29 |
32001286 | Enzymatically elongated rice starches by amylosucrase from Deinococcus geothermalis lead to slow down the glucose generation rate at the mammalian α-glucosidase level. | 2020 Apr 15 |
1 |
| 30 |
32089234 | Seaweed-derived bioactives as potential energy regulators in obesity and type 2 diabetes. | 2020 |
1 |
| 31 |
32194128 | Determination of glucose generation rate from various types of glycemic carbohydrates by mammalian glucosidases anchored in the small intestinal tissue. | 2020 Jul 1 |
1 |
| 32 |
32301514 | Persimmon highly galloylated-tannins in vitro mitigated α-amylase and α-glucosidase via statically binding with their catalytic-closed sides and altering their secondary structure elements. | 2020 Jul |
1 |
| 33 |
32802126 | Inhibition of Digestive Enzyme and Stimulation of Human Liver Cells (HepG2) Glucose Uptake by Date Seeds Extract. | 2020 |
1 |
| 34 |
32916220 | An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complications. | 2020 Nov |
2 |
| 35 |
33024458 | Differences in the effects of Kenyan, Tanzanian, and Ethiopian coffee intake on interstitial glucose levels measured by FreeStyle Libre: A pilot case study. | 2020 |
1 |
| 36 |
30599411 | Synthesis of benzothiazole derivatives as a potent α-glucosidase inhibitor. | 2019 Apr |
2 |
| 37 |
30604594 | Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. | 2019 Jun |
1 |
| 38 |
30776576 | Polyoxomolybdates as α-glucosidase inhibitors: Kinetic and molecular modeling studies. | 2019 Apr |
1 |
| 39 |
30954797 | Integrated multi-spectroscopic and molecular modelling techniques to probe the interaction mechanism between salvianolic acid A and α‑glucosidase. | 2019 Jul 5 |
1 |
| 40 |
30976294 | Fabrication of paper-based enzyme immobilized microarray by 3D-printing technique for screening α-glucosidase inhibitors in mulberry leaves and lotus leaves. | 2019 |
1 |
| 41 |
31019154 | Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones. | 2019 May 28 |
1 |
| 42 |
31071387 | Anthraquinone-type inhibitor of α-glucosidase enhances glucose uptake by activating an insulin-like signaling pathway in C2C12 myotubes. | 2019 Jul |
1 |
| 43 |
31333110 | Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update. | 2019 |
1 |
| 44 |
31404793 | Synthesis of novel (R)-4-fluorophenyl-1H-1,2,3-triazoles: A new class of α-glucosidase inhibitors. | 2019 Oct |
1 |
| 45 |
31493868 | MiR-26a and miR-26b downregulate the expression of sucrase-isomaltase enzyme: A new chapter in diabetes treatment. | 2019 Oct 29 |
1 |
| 46 |
31593486 | Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes. | 2019 Dec |
1 |
| 47 |
31672500 | Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes. | 2019 Dec |
1 |
| 48 |
32024621 | Alpha-glucosidase inhibition and molecular docking studies of 1,2-benzothiazine 1,1-dioxide based carbohydrazides. | 2019 Nov |
1 |
| 49 |
28950431 | Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis. | 2018 Jul |
1 |
| 50 |
29421697 | A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. | 2018 Apr |
1 |